Zim Laboratories Limited has informed the Exchange regarding a press release dated May 19, 2026, titled "ZIM Laboratories Limited Announces Grant of Marketing Authorization (MA) for Dabigatran Etexilate (75 mg, 110 mg & 150 mg) Capsules inItaly, Europe".